Tamoxifen has been consistently used for many years as an anti‐estrogen hormonal therapy for estrogen‐positive breast cancers, and the implications of tamoxifen on the nuclear estrogen receptors have been thoroughly described 36. This evidence concerns the gene ESR1 and breast carcinoma.